Clinical and molecular studies in full trisomy 22: Further delineation of the phenotype and review of the literature
Bacino CA, Schreck R, Fischel-Ghodsian N, Pepkowitz S, Prezant TR, Graham Jr JM. 1995. Clinical and molecular studies in full trisomy 22: further delineation of the phenotype and review of the literature. Am J Med Genet 56: 359-365.
Mosaic trisomy 22: A case presentation and literature review of trisomy 22 phenotypes
Crowe CA, Schwartz S, Black CJ, Jaswaney V. 1997. Mosaic trisomy 22: a case presentation and literature review of trisomy 22 phenotypes. Am J Med Genet 71: 406-413.
Congenital absence of the thymus and its immunologic consequences: Concurrence with congenital hypothyroidism
Good RA, Bergsma D (eds). National Foundation-March of Dimes: New York
DiGeorge AM. 1965. Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypothyroidism. In Birth Defects Original Article Series, vol, 4 Good RA, Bergsma D (eds). National Foundation-March of Dimes: New York; 116-121.
Type I diabetes mellitus in a patient with chromosome 22q11.2 deletion syndrome
Elder DA, Kaiser-Rogers K, Aylsworth AS, Calikoglu AS. 2001. Type I diabetes mellitus in a patient with chromosome 22q11.2 deletion syndrome. Am J Med Genet 101: 17-19.
Ring 22 duplication/deletion mosaicism: Clinical, cytogenetic, and molecular characterisation
Frizzley JK, Stephan MJ, Lamb AN, et al. 1999. Ring 22 duplication/deletion mosaicism: clinical, cytogenetic, and molecular characterisation. J Med Genet 36: 237-241.
The "cat eye syndrome": Dicentric small marker chromosome probably derived from a no. 22 (tetrasomy 22pter → q11) associated with a characteristic phenotype
Schinzel A, Schmid W, Fraccaro M, et al. 1981a. The "cat eye syndrome": dicentric small marker chromosome probably derived from a no. 22 (tetrasomy 22pter → q11) associated with a characteristic phenotype. Hum Genet 57: 148-158.